Comparisons for Evaluation of Efficacy and Safety of Cyclosporin A 0.05% Ophthalmic Emulsion Treatment Groups.
Soonwon Yang, Yong Soo Byun, Chang Rae Rho, Su Young Kim, Yang Kyung Cho, Eun Chul Kim, Sung Kun Chung, Choun Ki Joo
J Korean Ophthalmol Soc. 2016;57(12):1849-1856.   Published online 2016 Dec 15     DOI:
Citations to this article as recorded by Crossref logo
Comparison of the Effects of 0.05% and 0.1% Cyclosporine for Dry Eye Syndrome Patients after Cataract Surgery
Heeyong Han, Sangkyung Choi
Journal of the Korean Ophthalmological Society.2023; 64(11): 987.     CrossRef
Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction
Jay Won Rhim, Youngsub Eom, Eun Gyu Yoon, Seo Yeon Park, Young Choi, Jong Suk Song, Hyo Myung Kim
Japanese Journal of Ophthalmology.2022; 66(3): 254.     CrossRef
A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome
Ji Eun Lee, Sangyoon Kim, Hyung Keun Lee, Tae-Young Chung, Jae Yong Kim, Chul Young Choi, So Hyang Chung, Dong Hyun Kim, Kyoung Woo Kim, Jin Kwon Chung, Kyu Yeon Hwang, Ho Sik Hwang, Jin Hyoung Kim, Joon Young Hyon
Scientific Reports.2022;[Epub]     CrossRef
Comparison of Efficacy and Sensation of Instillation between 0.05% Cyclosporine Nanoemulsion and Microemulsion Type
Eun Hae Shin, Dong Hui Lim, Chan Min Yang, Tae-Young Chung
Journal of the Korean Ophthalmological Society.2019; 60(3): 239.     CrossRef
The Study on the Korean and Western Medical Literatures for Age-Related Macular Degeneration
Yu-Jin Jung, Woo-Shin Ko, Hwa-Jung Yoon
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology.2015; 28(3): 66.     CrossRef